| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 5.390 | 4.647 | 9.680 | 8.477 | 8.822 | 1.864 | 0 | 4.938 |
| Total Income - EUR | - | - | 5.390 | 4.647 | 9.680 | 8.477 | 8.822 | 1.864 | 0 | 4.968 |
| Total Expenses - EUR | - | - | 4.189 | 3.282 | 2.753 | 2.967 | 3.832 | 1.531 | 7.728 | 13.027 |
| Gross Profit/Loss - EUR | - | - | 1.201 | 1.365 | 6.927 | 5.510 | 4.990 | 333 | -7.728 | -8.059 |
| Net Profit/Loss - EUR | - | - | 1.039 | 1.226 | 6.637 | 5.320 | 4.884 | 294 | -7.728 | -8.108 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Prestige Myozah Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 1.504 | 3.214 | 9.638 | 6.381 | 11.387 | 11.541 | 4.273 | 8.216 |
| Inventories | - | - | 357 | 3.042 | 4.633 | 4.278 | 2.433 | 2.601 | 2.593 | 7.047 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 136 |
| Cash | - | - | 1.147 | 171 | 5.005 | 2.104 | 8.954 | 8.937 | 1.678 | 1.032 |
| Shareholders Funds | - | - | 1.083 | 2.288 | 8.881 | 5.382 | 10.146 | 10.471 | 2.711 | -5.412 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 421 | 925 | 757 | 999 | 1.241 | 1.069 | 1.561 | 13.628 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Prestige Myozah Srl